Discovery and design of benzimidazolone based inhibitors of p38 MAP kinase
Authors:
- Antonio BarbosaABAntonio Barbosa
- Faith Corbo GaenzlerFGFaith Corbo Gaenzler
- Tazmeen FadraTFTazmeen Fadra
- Daniel GoldbergDGDaniel Goldberg
- Ming-Hong HaoMHMing-Hong Hao
- Rachel R. KroeRKRachel R. Kroe
- Pingrong LiuPLPingrong Liu
- Kevin C. QianKQKevin C. Qian
- Mark RalphMRMark Ralph
- Christopher SarkoCSChristopher Sarko
- Fariba SoleymanzadehFSFariba Soleymanzadeh
- 1 December 2006
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 16 (24) , 6316-6320
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- The p38 MAP kinase pathway as a therapeutic target in inflammatory diseaseCurrent Opinion in Pharmacology, 2004
- SAR of benzoylpyridines and benzophenones as p38α MAP kinase inhibitors with oral activityBioorganic & Medicinal Chemistry Letters, 2004
- Novel biologic therapies for psoriasisExpert Opinion on Biological Therapy, 2004
- Biological Agents for Rheumatoid ArthritisDrugs, 2004
- Structure−Activity Relationships of the p38α MAP Kinase Inhibitor 1-(5-tert-Butyl-2-p-tolyl-2H-pyrazol-3-yl)-3-[4-(2-morpholin-4-yl-ethoxy)naph- thalen-1-yl]urea (BIRB 796)Journal of Medicinal Chemistry, 2003
- Thermal Denaturation: A Method to Rank Slow Binding, High-Affinity P38α MAP Kinase InhibitorsJournal of Medicinal Chemistry, 2003
- p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseasesNature Reviews Drug Discovery, 2003
- Pyrazole Urea-Based Inhibitors of p38 MAP Kinase: From Lead Compound to Clinical CandidateJournal of Medicinal Chemistry, 2002
- 4-Pyridin-5-yl-2-(3,4,5-trimethoxyphenylamino)pyrimidines: Potent and selective inhibitors of ZAP 70Bioorganic & Medicinal Chemistry Letters, 1999
- Design and Synthesis of Potent, Selective, and Orally Bioavailable Tetrasubstituted Imidazole Inhibitors of p38 Mitogen-Activated Protein KinaseJournal of Medicinal Chemistry, 1999